Suppr超能文献

大鼠卵黄囊癌(L2)细胞纤溶酶原系统的特性研究

Characterization of plasminogen system on rat yolk sac carcinoma (L2) cells.

作者信息

Kanalas J J

机构信息

Department of Pediatrics, University of Texas Health Science Center at San Antonio 78284-7813.

出版信息

Am J Physiol. 1995 Feb;268(2 Pt 1):C442-8. doi: 10.1152/ajpcell.1995.268.2.C442.

Abstract

The plasminogen (Plg) system on rat yolk sac carcinoma (L2) cells was characterized by zymography, Western and immunoprecipitation analysis, reverse-transcriptase polymerase chain reaction, binding, and activity assays. The L2 cells produced tissue Plg activator but not urokinase Plg activator and contained RNA for Plg activator inhibitor 1, but Plg activator inhibitor 1 was not detectable by zymography or Western analysis and contained the receptor for urokinase Plg activator. Plg bound to the cells in a saturable manner when plasmin inhibitors were present with a dissociation constant of 1.34 +/- 0.18 x 10(-6) M and 1.54 +/- 0.25 x 10(7) sites/cell. Immunoprecipitation analysis showed that Plg was binding to gp330, a known Plg receptor. Once bound to the L2 cells, Plg was activated by tissue Plg activator to plasmin in a time- and concentration-dependent manner. Under saturating Plg conditions, most of the plasmin produced was released into the medium. Inhibition of plasmin activation occurred when Plg activator inhibitor 1, anticatalytic tissue Plg activator antibody, or Heymann nephritis autoantibody was present.

摘要

通过酶谱分析、蛋白质免疫印迹和免疫沉淀分析、逆转录聚合酶链反应、结合及活性测定等方法,对大鼠卵黄囊癌(L2)细胞上的纤溶酶原(Plg)系统进行了表征。L2细胞产生组织型纤溶酶原激活物,但不产生尿激酶型纤溶酶原激活物,含有纤溶酶原激活物抑制剂1的RNA,但通过酶谱分析或蛋白质免疫印迹分析未检测到纤溶酶原激活物抑制剂1,且含有尿激酶型纤溶酶原激活物的受体。当存在纤溶酶抑制剂时,Plg以可饱和的方式与细胞结合,解离常数为1.34±0.18×10⁻⁶ M,每个细胞有1.54±0.25×10⁷个结合位点。免疫沉淀分析表明,Plg与已知的Plg受体gp330结合。一旦与L2细胞结合,Plg被组织型纤溶酶原激活物以时间和浓度依赖的方式激活为纤溶酶。在Plg饱和的条件下,产生的大部分纤溶酶被释放到培养基中。当存在纤溶酶原激活物抑制剂1、抗催化性组织型纤溶酶原激活物抗体或海曼肾炎自身抗体时,纤溶酶激活受到抑制。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验